FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and is an antibiotic formulation comprising at least one silver-containing compound, including an anti-microbial agent containing an aliphatic silver carboxylate, wherein said silver of aliphatic silver carboxylate having a nominal valence of 2, wherein said at least one silver-containing compound having an average valence of at least 1.1; and a carrier base. Said at least one silver-containing compound is dispersed within said base. Antibiotic formulation does not darken or shows a slight darkening with an increase in the concentration of the silver-containing anti-microbial agent.
EFFECT: invention has antibiotic properties, that is it can kill microorganisms, and selectively demonstrates the relative inertness to human cells.
20 cl, 14 dwg, 3 tbl, 118 ex
